New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours

New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours

Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.

By Julie Crljen|2021-06-02T16:05:59-04:00April 6th, 2021|Categories: News, Research Publication, Team Projects|Tags: Cindi Morshead, cycle 2, endogenous repair, Freda Miller, metformin, neuroscience, team projects|

U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer

Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated

By Julie Crljen|2021-06-02T16:11:10-04:00July 27th, 2020|Categories: News, Research, Research Publication, Team Projects|Tags: Cindi Morshead, clinical translation, convergence, cycle 2, endogenous repair, Freda Miller, metformin, neural|

A diabetes drug promotes brain repair — but only in females, U of T study shows

Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only

By Ann Perry|2022-04-12T18:31:08-04:00September 13th, 2019|Categories: Research, Research Publication|Tags: diversity, metformin, neural|